Parnassus Investments, LLC Alnylam Pharmaceuticals, Inc. Transaction History

Parnassus Investments, LLC

  • $45.6 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 08, 2023
BUY
$170.77 - $211.65 $6.62 Million - $8.2 Million
38,748 New
38,748 $6.86 Million
Q3 2022

Nov 14, 2022
SELL
$138.54 - $232.0 $4.44 Million - $7.44 Million
-32,068 Reduced 55.25%
25,970 $5.2 Million
Q2 2022

Aug 05, 2022
SELL
$120.42 - $169.29 $2.35 Million - $3.31 Million
-19,549 Reduced 25.2%
58,038 $8.47 Million
Q4 2020

Feb 10, 2021
BUY
$122.97 - $147.0 $9.54 Million - $11.4 Million
77,587 New
77,587 $10.1 Million

Others Institutions Holding ALNY

# of Institutions
642
Shares Held
109M
Call Options Held
1.28M
Put Options Held
1.21M
View Full List

About ALNYLAM PHARMACEUTICALS, INC.

ALNY Quotes by TradingView
  • Ticker ALNY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 123,028,000
  • Market Cap $30.1B
  • Description
  • Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...
More about ALNY
Track This Portfolio

Track Parnassus Investments, LLC Portfolio

Follow Parnassus Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parnassus Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parnassus Investments, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email